Animal study suggests that newborn period may be crucial time to prevent later diabetes
Children's Hospital of Philadelphia researchers use a diabetes drug to permanently reprogram insulin-producing cells
2011-11-03
(Press-News.org) Pediatric researchers who tested newborn animals with an existing human drug used in adults with diabetes report that this drug, when given very early in life, prevents diabetes from developing in adult animals. If this finding can be repeated in humans, it may become a way to prevent at-risk infants from developing type 2 diabetes.
"We uncovered a novel mechanism to prevent the later development of diabetes in this animal study," said senior author Rebecca A. Simmons, M.D., a neonatologist at The Children's Hospital of Philadelphia. "This may indicate that there is an important developmental window, a period of time in which we can intervene to permanently protect the body's insulin-producing cells."
Simmons and lead author Sara E. Pinney, M.D., a pediatric endocrinologist at Children's Hospital, published the study in the October issue of Diabetologia.
The research may be relevant to children with intrauterine growth retardation (IUGR), a common complication during the mother's pregnancy. Simmons' previous research showed that IUGR, which is associated with decreased availability of nutrients and hormones to the developing fetus, permanently alters gene expression and impairs the function of insulin-producing cells in the pancreas. These defects have been shown to cause type 2 diabetes to develop in adulthood.
The study team used exendin-4 (Ex-4), a drug recently approved for use in adults with type 2 diabetes—a condition in which a patient produces insufficient insulin, or is unable to process insulin normally. Although the drug's mechanism is not known, it has a hormone-like effect, raising insulin secretion in adults.
In their study, Simmons and Pinney used rats with an induced form of IUGR. They found that after being given to newborn rats, Ex-4 had epigenetic effects—modifying gene function without changing the underlying DNA sequences. Ex-4 increased the expression of a gene called Pdx1 that is necessary for beta cells to function properly. Beta cells produce insulin in the pancreas of mammals, including humans.
"In our study, giving exendin-4 during the newborn period had permanent beneficial effects on beta cells," said Pinney. "This could be important for people, in whom abnormal changes in infancy may irreversibly alter beta cells and lead to adult-onset diabetes. If we can establish that treating at-risk human babies with exendin-4 or a similar compound has corresponding effects, we may have a new preventive approach for type 2 diabetes."
Simmons and Pinney cautioned that much follow-up research remains to be done, such as investigating more of the basic biology and evaluating the genome-wide effects of exendin-4, before their research findings could translate into clinical use in children.
INFORMATION:
The National Institutes of Health, the Lawson Wilkins Pediatric Endocrine Research Fellowship and the University of Pennsylvania Institute of Translational Medicine and Therapeutics Fellowship supported this study. Co-authors with Simmons and Pinney were L.J Jaeckle Santos and Y. Han, all from both Children's Hospital and the Perelman School of Medicine of the University of Pennsylvania (Penn). D.A. Stoffers, of Penn, also was a co-author.
"Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat," Diabetologia, October 2011 print issue. doi: 10.1007/s00125-011-2250-1.
About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 516-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-11-03
Antibodies Trick Bacteria into Killing Each Other
The dominant theory about antibodies is that they directly target and kill disease-causing organisms. In a surprising twist, researchers from the Albert Einstein College of Medicine have discovered that certain antibodies to Streptococcus pneumoniae actually trick the bacteria into killing each other.
Pneumococcal vaccines currently in use today target the pneumococcal capsular polysaccharide (PPS), a sort of armor that surrounds the bacterial cell, protecting it from destruction. Current thought hold that PPS-binding ...
2011-11-03
Solar power may be on the rise, but solar cells are only as efficient as the amount of sunlight they collect. Under the direction of a new professor at Northwestern University's McCormick School of Engineering and Applied Science, researchers have developed a new material that absorbs a wide range of wavelengths and could lead to more efficient and less expensive solar technology.
A paper describing the findings, "Broadband polarization-independent resonant light absorption using ultrathin plasmonic super absorbers," was published Tuesday in the journal Nature Communications.
"The ...
2011-11-03
BUFFALO, N.Y. -- Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown.
The study of the drug, marketed under the trade name Byetta, was published recently in the Journal of Clinical Endocrinology and Metabolism.
"Our most important finding was this rapid, anti-inflammatory effect, which may lead to the inhibition of atherosclerosis, the major cause of heart attacks, strokes and gangrene in diabetics," says Paresh Dandona, ...
2011-11-03
WASHINGTON, Nov. 2—In the emerging field of tissue engineering, scientists encourage cells to grow on carefully designed support scaffolds. The ultimate goal is to create living structures that might one day be used to replace lost or damaged tissue, but the manufacture of appropriately detailed scaffolds presents a significant challenge that has kept most tissue engineering applications confined to the research lab. Now a team of researchers from the Laser Zentrum Hannover (LZH) eV Institute in Hannover, Germany, and the Joint Department of Biomedical Engineering at the ...
2011-11-03
Oversensitivity diseases, or allergies, now affect 25 per cent of the population of Denmark. The figure has been on the increase in recent decades and now researchers at the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), University of Copenhagen, are at last able to partly explain the reasons.
"In our study of over 400 children we observed a direct link between the number of different bacteria in their rectums and the risk of development of allergic disease later in life," says Professor Hans Bisgaard, consultant at Gentofte Hospital, head of the Copenhagen ...
2011-11-03
Philadelphia, PA, November 2, 2011 – Cardiovascular Magnetic Resonance (CMR) has undergone substantial development and offers important advantages compared with other well-established imaging modalities. In the November/December issue of Progress in Cardiovascular Diseases, published by Elsevier, a series of articles on key topics in CMR will foster greater understanding of the rapidly expanding role of CMR in clinical cardiology.
"Until a decade ago, CMR was considered mostly a research tool, and scans for clinical purpose were rare," stated guest editors Theodoros ...
2011-11-03
The world may seem painted with endless color, but physiologically the human eye sees only three bands of light — red, green, and blue. Now a Tel Aviv University-developed technology is using colors invisible to the naked eye to analyze the world we live in. With the ability to detect more than 1,000 colors, the "hyperspectral" (HSR) camera, like Mr. Spock's sci-fi "Tricorder," is being used to "diagnose" contaminants and other environmental hazards in real time.
Prof. Eyal Ben-Dor of TAU's Department of Geography and the Human Environment says that reading this extensive ...
2011-11-03
One of two proteins that regulate nerve cells and assist in overall brain function may be the key to preventing long-term damage as a result of a stroke, the leading cause of disability and third leading cause of death in the United States.
In a recent study published in the Journal of Neuroscience, Bonnie Firestein, professor of cell biology and neuroscience, in the School of Arts and Sciences, says the new research indicates that increased production of two proteins – cypin and PSD-95 – results in very different outcomes.
While cypin – a protein that regulates nerve ...
2011-11-03
Cold Spring Harbor, N.Y. – Cancer cells maintain their life-style of extremely rapid growth and proliferation thanks to an enzyme called PK-M2 (pyruvate kinase M2) that alters the cells' ability to metabolize glucose – a phenomenon known as the Warburg effect.
Professor Adrian Krainer, Ph.D., and his team at Cold Spring Harbor Laboratory (CSHL), who seek to reverse this effect and force cancer cells to regain the metabolism of normal cells, have discovered details of molecular events that cause cancer cells to produce PK-M2 instead of its harmless counterpart, an isoform ...
2011-11-03
The discovery of 13 diffuse interstellar bands with the longest wavelengths to date could someday solve a 90-year-old mystery.
Astronomers have identified the new bands using data collected by the Gemini North telescope of stars in the center of the Milky Way.
Nature reports on its website today findings that support recent ideas about the presence of large, possibly carbon-based organic molecules—"carriers"—hidden in interstellar dust clouds. The paper will also appear in the Nov. 10 print issue of the journal.
"These diffuse interstellar bands—or DIBs—have never ...
LAST 30 PRESS RELEASES:
[Press-News.org] Animal study suggests that newborn period may be crucial time to prevent later diabetes
Children's Hospital of Philadelphia researchers use a diabetes drug to permanently reprogram insulin-producing cells
